A typical form of microangiopathy, consisting of micro vascular rarefaction and endothelial barrier dys function, contributes to the pathogenesis of retinopathy, nephropathy, neuropathy, cardiomyopathy, and foot ulcers in patients with diabetes mellitus. 1 Our group was the first to describe a new form of microangiopathy in the bone mar row (BM) of diabetic animal models. 2 Microvascular dis ease threatens stem cell viability through reduced nutrition and perfusion, and increased oxidative stress. In addition, the marrow vascular niche acts as a controller of stem cell mobilization and a source of trophic factors instrumental to proper hematopoiesis. [3] [4] [5] [6] An impoverished vascular niche might fail to accomplish these crucial functions with detri mental consequences for stem cell homeostasis and cardio vascular repair. 7 Glycemic control is crucial for prevention of cardiovas cular events, and especially effective in reducing the risk of microvascular complications. However, it remains unknown whether improved control of hyperglycemia by insulin replacement prevents BM microangiopathy. Furthermore, the mechanisms underpinning BM endothelial dysfunction remain poorly understood.
The present study investigates the signaling path ways implicated in diabetes mellitus-induced BM micro angiopathy. Results newly show that diabetes mellitus causes redoxdependent activation of small guanosine triphosphatases (GTPases), phosphorylation of vascular endothelial cadherin (VEcadherin), and reorganization of cytoskeletal proteins leading to increased permeability to macromolecules and passive efflux of BM mononuclear cells (BMMNCs). Furthermore, the diabetic endothelium exhibits reduced Akt activity and impairment of Aktrelated functions, including migration, network formation, and angiocrine factor-releasing activity. Importantly, endothelial barrier dysfunction is rescued by the metabolic control of diabetes mellitus.
Insulin Implants
Four weeks after induction of diabetes mellitus, mice were random ized to receive continuous insulin supplementation, through subcu taneous implants (LinBit, LinShin, Toronto, Canada), at the rate of 0.1 unit/implant per day or vehicle. The number of insulin implants was titrated according to the mouse body weight, according to manu facturer's instructions. Glycaemia was monitored every 4 weeks, whereas glycosuria was assessed at 2 weeks after diabetes melli tus induction and reassessed at the end of the study ( Figure I 
Cell Cultures
Human BM endothelial cells (hBMECs) were kindly provided by Prof van der Schout (Sanquin University, Amsterdam, The Netherlands) and cultured as described previously. 10 In selected experiments, cells were cultured in normal glucose (5 mmol/L Dglucose) or high glu cose (HG; 15 mmol/L and 25 mmol/L Dglucose) for 96 hours before use in expressional and functional studies. Equivalent concentrations of Lglucose were used as osmotic control.
BMECs were also isolated from T1D mice (14-18 weeks after dia betes mellitus induction) and agematched nondiabetic controls, as described previously. 2 Purity was assessed by flow cytometry detec tion of the endothelial marker MECA32, which was consistently expressed by >90% of the isolated cells.
Infection of BMECs
BMECs were infected separately with 2 different adenoviruses: an adenovirus carrying constitutively active myristoylated Akt and an adenovirus carrying the dominant negative form of RhoA. 11, 12 AdNull (empty vector Ad66) was used as control. BMECs were grown in complete medium in 10cm petri dishes until 60% to 70% confluent, and then infected overnight with adenoviral vectors at 200 multiplic ity of infection for both adenoviruses. The medium was then changed and cells were used for experiments after 2 days.
Illumina Gene Array
An Illumina beadarray interrogating 24 600 murine transcripts was performed on T1D and control BMECs (4 biological replicates each). Microarray expression data are available at the NCBI Gene Expression Omnibus (GEO) (http://www.ncbi.nlm.nih.gov/geo/) under accession number GSE14035.
Differentially expressed genes were associated with biofunction networks and canonical pathway using Ingenuity Pathway Analysis software core analysis (Ingenuity Systems, Redwood City, CA, www. ingenuity.com). Transcripts with expression changes at false discovery rate (qvalue) <0.05, induced or repressed >1.25fold, were associated with biological functions in Ingenuity Knowledge database, and the association was tested for statistical significance as described below.
Flow Cytometry Staining of BMECs
Freshly harvested BM cells were washed with icecold Hank balanced salt solution containing 0.5% bovine serum albumin and 0.02% sodium azide. To recognize endothelial cells (ECs), BM cells were stained with anti-MECA32 biotinconjugated antibody (BD Biosciences, Oxford, UK), followed by streptavidin-allophycocyanin-conjugated secondary antibody.
Detection of Oxidative Stress Markers
HBMECs were seeded on 6well plates, cultured until reaching conflu ence, and then assessed for reactive oxygen species (ROS) levels by flow cytometry detection of MitoSox red (Invitrogen, Carlsbad, CA), a mitochondriaspecific hydroethidinederivative fluorescent dye, or DCF (Molecular Probes, Paisley, UK), a marker of total oxidative stress. Four separate experiments in triplicates were analyzed and averaged.
In addition, BMECs were seeded in 8chamber slide wells and stained for 45 minutes with MitoTracker Red CmH 2 ROS (500 nmol/L) at 37°C. Cells were fixed with paraformaldehyde, and pic tures were taken with identical settings for all conditions.
In Vitro Permeability Assay
HBMECs and BMECs were seeded onto transwell inserts (pore size: 0.3 µm) coated with 0.5 μg/mL fibronectin, and grown until they reached confluence. Then, the media was replaced in the lower chamber and fresh media containing 70 kDa fluorescein isothiocyanatelabeled dextran was added to the upper chamber. The increase in fluorescence in the lower chamber was evaluated at different time points over 16 hours, with identical exposure settings using FLUOstar Optima fluo rimeter (Berthold Technologies Wildbad, Germany). Three indepen dent experiments in triplicate were analyzed and averaged.
In Vivo Permeability Assay
Mice were intracardially injected with a 500 µL bolus of 70 kDa fluo rescein isothiocyanatelabeled dextran (200 µM), followed after 3, 5, or 7 minutes by an equal bolus of 70 kDa tetramethylrhodamine isothiocyanatelabeled dextran (n=3 mice each time point). Animals were euthanized 30 seconds after the last injection. Fluorescein iso thiocyanate and tetramethylrhodamine isothiocyanate fluorescence was measured using a FLUOstar Optima fluorimeter, with identical exposure settings for all conditions in plasma and in bone flushes.
Data were plotted as mg fluorescein isothiocyanate (I F ) in BM interstitium per mg BM tissue (W) against time. Three independent experiments were carried out for each time point and condition.
Transendothelial Migration of BM-MNCs
Transendothelial migration of BMMNCs was assessed using tran swell cell culture inserts equipped with 3μm pore size filters (BD Biosciences) using stromal cell-derived factor1 as the chemoat tractant. BMMNCs from T1D and control mice were labeled with chloromethyldyalkilcarbocyanine (Life Technologies, NY), and then added to the top compartment (3×10 5 cells per well in 300 μL). After 16 hours incubation at 37°C, nonmigrated cells on the upper side of the membrane were removed by scraping. All inserts were fixed for 10 minutes in methanol and mounted on slides counterstained with 4′,6diamidino2phenylindole. Three separate experiments in tripli cates were analyzed and averaged.
BMEC Migration
Migration of cultured BMECs was studied, as described previously. 13 Briefly, BMECs were seeded on the upper part of 24transwell plate filters coated with fibronectin. The lower wells contained basal medium supplemented with vascular endothelial growth factor A (100 ng/mL, R&D, Abingdon, UK). After 8 hours incubation, BMECs migrated to the lower part of the filter membrane were counted. Five random fields per each filter were evaluated at ×200 magnification using a fluorescent microscope (Olympus). Four separate experiments in triplicate were performed.
Matrigel Assay
BMECs (3×10 4 in a total volume of 100 µL Dulbecco's modified Eagle's medium) were added on top of 100 µL gelified, growth enriched Matrigel (BD Biosciences, Oxford, UK) in each well of 8well chamber slides. After 8 hours at 37°C, gels were washed gently with sterile PBS and fixed with 2% paraformaldehyde, and then mounted with glycerol. Three samples per group were analyzed in triplicate to compute the cumulative tube length of the endothelial network.
Immunohistochemistry and Immunocytochemistry
Paraffinembedded sections (5 µm thick) of BM from T1D and con trol mice (n=6 per group) were used for in situ identification of vascu lar structures (Alexa Fluor 568conjugated isolectin B4 [Invitrogen]) expressing phosphorylated VEcadherin (VEcad pY731 or pY658 rabbit polyclonal antibodies [Invitrogen]). A goat antirabbit Alex488 was used as secondary antibody (Invitrogen). All samples were coun terstained with 4′,6diamidino2phenylindole. Microphotographs were taken with a Leica SP5 confocal imaging system (Leica, Milton Keynes, UK) at ×400 magnification.
To study cytoskeletal rearrangements, BMECs were stained with rhodamine phalloidin (Sigma). Five images per field were captured at ×200 magnification using a fluorescent microscope (Olympus, Southend on Sea, UK).
Quantitative PCR
Total RNA was isolated from murine BMECs (RNeasy, Qiagen, Manchester, UK), and RNA quality confirmed using the RNA Nano LabChip in a bioanalyzer (Agilent, Stockport, UK). RNA was reverse transcribed (Sensiscript reverse transcriptase, Qiagen, Crawley, UK) and quantitative PCR was performed in a LightCycler480 (Roche). Primers for PCR amplification for housekeeping gene, 18S rRNA, used were: forward, GATCTGCTCATTTGCTGCCG; reverse, GTGTGGTGGCTGATACATTTGAT. The ΔCt obtained was used to find the gene relative expression according to the formula: relative expression=2 -ΔΔCt , where ΔΔCt is equal to ΔCt of a given gene in experimental group subtracted by the ΔCt of the same gene in con trol group. The analyses were performed on at least 4 samples per time and repeated 3 times. Primers used are detailed in Table I in the onlineonly Data Supplement.
Assay for Akt Activity
Protein preparations (25 µg) from BMECs of T1D and control mice were assessed for Akt activity using the Kinase Activity Assay Kit, according to the manufacturer's instructions (Enzo Life Sciences, Exeter, UK). Three independent experiments in triplicate were performed.
Assay for Rho Activity
GTPbound active Rho was assessed by pulldown assays, according to the manufacturer's instructions (Millipore, Billerica, MA).
Western Blot
The analysis of protein expression was performed on lysates from con fluent hBMECs and BMECs using phosphospecific antibodies against antiphospho Ser 1177 endothelial nitric oxide synthase (eNOS) (Cell signaling technologies), NADPH oxidase isoform 2 (BD Biosciences, Oxford, UK), VEcadherinY731, VEcadherinY658, and Pyk2Y402 (Cell Signaling Technologies, MA), antibodies raised against respec tive total proteins and a monoclonal antibody for recognition of tubulin. Blots were analyzed with an enhanced chemiluminescence detection system (Amersham Biosciences, Buckinghamshire, UK).
Immunoprecipitation
Membrane samples were obtained, as described previously, 14 in lysis buffer, 20 mmol/L TrisHCL, 150 mmol/L NaCl, 1 mmol/L EDTA, 1 mmol/L ethylene glycol tetraacetic acid, 1% TritonX, 2.5 mmol/L sodium pyrophosphate, 1 mmol/L βglycerophosphate, 1 mmol/L Na 3 VO 4 , 1 μg/mL leupeptin. Cav1 was immunoprecipitated using anti Caveolin1 (Cav1) antibody (Abcam) and protein A (Santa Cruz). After washing of the immune complexes in wash buffer, 20 mmol/L TrisHCl, 137 mmol/L NaCl, 1% TritonX, 2 mmol/L EDTA, the com plexes were run on a SDSPAGE gel and blotted for total eNOS (Cell Signaling Technologies). Samples incubated with nonimmune rabbit IgG, instead of anti-Cav1 antibody, were used as controls.
Data Analysis and Statistical Procedures
Values are presented as mean±SEM. If data failed to pass normality and equal variance tests, a nonparametric analysis was applied and results were expressed as median with 5 to 95 percentile distribu tion. Multiple groups were compared by parametric 2way ANOVA, followed by Bonferroni post t test, 1way ANOVA, followed by Bonferroni Multiple Comparison test, or nonparametric ANOVA on ranks, followed by Tukey pairwise comparison or Dunnett test for multiple comparisons against a single control group. Comparison of 2 groups was performed by paired or unpaired Student t test. In gene array studies, the righttailed Fisher exact test was used to evaluate the probability that the association of differentially expressed genes and biological functions or canonical pathways is because of chance. The significance of the association between the data set and a given canon ical pathway was also measured as the ratio of the number of differen tially expressed genes in a pathway and the total number of genes in the same pathway. A P value <0.05 was considered significant.
Results
To determine the mechanisms underlying BM endotheliopa thy, we performed an Illumina gene array on primary BMECs isolated from T1D (18 weeks from diabetes mellitus induc tion) and agematched nondiabetic mice. Of 792 transcripts with expression changes at false discovery rate (q value) <0.05, 448 were induced or repressed >1.25fold. Table II in the onlineonly Data Supplement shows the list of differ entially expressed genes within canonical pathways. Among topranked functions, Ingenuity Pathway Analysis showed a highly significant effect of diabetes mellitus on signaling pathways associated with cellular death, assembly, organiza tion, trafficking, and inflammation ( Figure 1A) .
Functional enrichment analysis identified small GTPases (RhoA and CDC42), actin cytoskeleton dynamics, integrin, leukocyte extravasation, and tight junctions, as the signaling pathways most enriched with differentially expressed genes ( Figure 1B) . Moreover, within the actin cytoskeleton and leukocyte extravasation/vascular permeability signaling pathways, we found that 14 of 209 and 12 of 183 genes, respectively, were modulated by diabetes mellitus (Figure II in the onlineonly Data Supplement). Actinrelated protein 2/3 (nucleation site for actin filaments polymerization), membrane organizing extension spike protein (moesin, a crosslinker between the endothelial plasma membrane and actinbased cytoskeleton), and the Rhoassociated kinase2 (ROCK2, an activator of moesin through phosphorylation on Thr558) were all upregulated in diabetic BMECs.
Taken together, these gene array data indicate transcrip tional alterations compatible with loosened adhesive intercel lular contacts and increased endothelial permeability. 11
Altered RhoA/ROCK and Akt Activity in Diabetic BM Endothelium
RhoA and ROCK regulate a wide range of cellular functions, including cytoskeletal rearrangement, migration, and prolif eration. Using a RhoA-GTPbound pulldown assay, we found that diabetes mellitus increases Rho activity in BMECs (Figure 2A ). It is known that oxidative stress is a potent inducer of RhoA. [15] [16] [17] Here, we confirm our previous finding of increased oxidative stress at the mitochondrial level in T1D BMECs (Figure IIIA in the onlineonly Data Supplement). 2 Moreover, we found polyADPribose polymerase 1 to be upregulated and transcription factor nuclear factor (erythroid derived 2)like 2 (Nfr2) downregulated in T1DBMECs ( Figure IIIB in the onlineonly Data Supplement). It is known that oxidative stress induces DNA strain breaks, which in turn activate polyADPribose polymerase, 18, 19 whereas Nfr2 exerts antioxidant activity to protect vascular cells from HGinduced damage. [19] [20] [21] In contrast, the expression of NADPH oxidase isoform 2, another important source of ROS, was similar in BMECs from healthy and diabetic mice ( Figure IIIC in the onlineonly Data Supplement). Thus, oxidative stress in BM endothelium is attributable to increased ROS production in mitochondria and reduced antioxidant defense. In accordance, we found that preconditioning T1DBMECs with the ROS scavenger, Nacetylcysteine (NAC), inhibits RhoA activation (Figure 2A ). Furthermore, RhoA upregulation was accompanied by increased ROCK1 and ROCK2 mRNA levels, which was again prevented by NAC ( Figure 2B ).
The influence of activated RhoA on Akt is controversial, with reports indicating that RhoA/ROCK causes induction 22 or suppression of Akt activity in ECs. 23 We found that Akt activity is remarkably depressed in diabetic BM endothelium. Notably, this deficit was partially reverted by NAC, the ROCK inhibitor Y27632, or by transfecting cells with adenovirus car rying the dominant negative form of RhoA ( Figure 2C) , thus suggesting that small GTPase activation by oxidative stress is responsible for Akt inhibition.
Akt activation in ECs reportedly induces the release of angi ocrine factors that support BM stem cell expansion. 3 Several of these angiocrine substances, such as fibroblast growth fac tor 2, JAGGED1, and JAGGED2, were downregulated in dia betic BMECs, but restored after antioxidant treatment ( Figure  2D and 2E) . The ROCK inhibitor Y27632 and RhoA knock down recovered fibroblast growth factor 2, but not JAGGED1 and JAGGED2 mRNA expression ( Figure 2D ).
Rescue of Endothelial Dysfunction by ROCK Inhibition or Akt Activation
We next investigated whether an altered RhoA-Akt axis has specific consequences for the BMEC functiontype. Akt is a potent inducer of eNOS activity, which synthesizes nitric oxide, a key molecule in EC function. In total membrane frac tions from T1D BMECs, we observed a decrease in eNOS phosphorylation as well as a reduction in Cav1 expression. Cav1 negatively regulates eNOS by directly interacting with it. Immunoprecipitation of Cav1 confirmed that Cav1 and eNOS interact both in Ctrl and T1D BMECs ( Figure 3A and 3B). Taken together, these data suggest a reduced nitric oxide (NO) availability in diabetic cells.
We next investigated the effect of Akt activation (by transfection of BMECs with a constitutively active form), of RhoA knocking down (by a transfection with a dominant negative form), and of pharmacological ROCK inhibition with the compound Y27632. Successful transduction of cells by adenovirus carrying constitutively active myristoylated Akt and adenovirus carrying the dominant negative form of RhoA was documented by Western blot for Akt and Rho activity assay ( Figure IIID and IIIE in the onlineonly Data Supplement).
In a network formation assay on matrigel, T1DBMECs showed reduced tubeformation capacity, which was restored by constitutively active Akt, adenovirus carrying the dominant negative form of RhoA, or ROCK inhibition ( Figure 3C ). In addition, T1DBMECs displayed a reduced migratory response to vascular endothelial growth factor A, with this defect being partially recovered by Akt activation, but not by RhoA/ROCK inhibition ( Figure 3D ). ROS are known to induce the rearrange ment of Factin stress fibers and cell contraction via RhoA-ROCK activation and phosphorylation of moesin, 24 resulting in increased endothelial permeability. 25, 26 We asked whether this mechanism is activated in T1DBMECs. Accordingly, we found that diabetes mellitus triggers the formation of Factin stress fibers in BMECs, which is reduced by ROCK inhibition and to a lesser extent by Akt activation ( Figure 4A ). Furthermore, moesin mRNA ( Figure 4B ) and protein phosphorylation lev els ( Figure 4C ) were increased in T1DBMECs, with the latter effect being blunted by NAC and ROCK inhibitor Y27632.
We next asked whether ROS and ROCKdependent acti vation of BMEC cytoskeleton translates into increased endo thelial permeability and barrier dysfunction. Sizeselective assessment of paracellular permeability was performed using fluorescently labeled dextran. Figure 4D shows that the T1DBMEC monolayer is more permeable to dextran compared with BMECs from healthy mice. This increased permeability was prevented by NAC, myristoylated Akt, and RhoA/ROCK inhibition. The presence of endothelial barrier dysfunction was further assessed using a transen dothelial migration assay on BMMNCs. Results confirm our previous findings indicating that spontaneous transen dothelial migration of BMMNCs is increased in the pres ence of diabetic BMECs compared with control BMECs, whereas directed migration toward stromal cellderived fac tor1 is abolished. 2 Moreover, we newly show that endothe lial barrier function is rescued, in part, by ROS scavenging and RhoA/ROCK inhibition ( Figure 4E ). In contrast, Akt activation did not reduce the increased basal migration of BMMNCs, but restored responsiveness to stromal cellderived factor1. Altogether, these data indicate that the Rho/ROCK-Akt axis plays a crucial role in the functional alterations of dia betic BMECs.
HG Increases BMEC Permeability Through VE-Cadherin Phosphorylation
We next investigated the direct effect of HG on BMEC permeability. To this end, we established an in vitro model consisting of hBMECs cultured in normal (5 mmol/L, normal glucose) or high (15 and 25 mmol/L, HG) Dglucose for 96 hours. ROS levels were augmented by progressive increases of glucose concentration, as assessed by flow cytometry detection of MitoSox and 2′,7′dichlorofluorescein2A. The ROS production was brought back to control levels totally by catalase treatment, and partially reduced by superoxide inhibitor and antioxidant diethyldithiocarbamate ( Figure  IVA in the onlineonly Data Supplement). Moreover, HG alters hBMEC permeability in a dosedependent manner, as assessed in an in vitro assay using 70 kDa dextran (Figuve IVB in the onlineonly Data Supplement). The increase in permeability was completely reversed by treating hBMECs with NAC or catalase; however, neither the hydroxyl scavenger MCI186 nor diethyldithiocarbamate modified the effect of HG on permeability. The inhibition of detoxifying chain at superoxide level suggests that this ROS, and the ones generated as peroxynitrite, can trigger molecular changes leading to increased permeability.
ROS reportedly modifies the activity of several tyrosine kinases. 27 Among them, Src increases vascular permeability through phosphorylation of VEcadherin, a key component of EC adherens junctions. 28 We found that HG increases the phosphorylation of VEcadherin at Y731 and Y658, which are binding sites for βcatenin and p120, respectively. Moreover, VEcadherin phosphorylation was prevented by both NAC treatment and Src inhibition, suggesting a pivotal role of Src kinase in adherens junction disassembly through a redoxsen sitive mechanism (Figure VA and VB in the onlineonly Data Supplement). Of note, the HGinduced increase in permeabil ity was reverted by Src inhibitor SU6656 ( Figure IVB in the onlineonly Data Supplement). Another redoxsensitive kinase controlling adherens junctions is represented by the prolyne rich kinase 2 (Pyk2), which has the same targets as Src. In accor dance, the active phosphorylated form of Pyk2 was increased in hBMECs under HG. This effect was totally prevented by NAC ( Figure VC in the onlineonly Data Supplement).
In addition, we found that the proapoptotic and proinflam matory redoxsensitive kinases p38 29 and cJun Nterminal kinases 30 are activated in both HGtreated hBMECs and T1DBMECs. This effect was reversed by NAC and cata lase. Finally, the MAPK kinase kinase, MEK1, which control angiogenesis and proliferation in ECs, was found increased in HBMECs treated with HG, but not in diabetic cells ( Figure VI in the onlineonly Data Supplement).
Redox-Dependent Activation of VE-Cadherin in BMEC Leads to Endothelial Barrier Dysfunction in T1D Mice
We next asked whether phosphorylation events associated with VEcadherin activation occur in BMECs from diabetic mice.
As for HGtreated hBMECs, phosphorylation of VEcadherin and Pyk2 was increased in diabetic murine BMECs, but reduced by NAC ( Figure 5A-5C ). Fluorescence microscopy demonstrated in situ phosphorylation of VEcadherin in BM vascular cells of T1D mice ( Figure 5D and Figure VII in the onlineonly Data Supplement).
Finally, we assessed the abundance of BMECs by flow cytometry of MEC32positive cells and BM endothelial barrier function in vivo using a double tracer technique. We found that MECA32-positive ECs are reduced in BM of T1D mice ( Figure  6A and 6B) . Moreover, vascular permeability is increased by diabetes mellitus (Figure 6C and 6D) , which was confirmed at different times from diabetes mellitus induction ( Figure VIIIA and VIIIB in the onlineonly Data Supplement). To verify whether the observed changes can be contrasted by metabolic control, we treated diabetic animals with insulin implants. Of note, insulin replacement resulted in maintenance of BMECs abundance and normalization of vascular permeability ( Figure  6A-6D ). Furthermore, in vitro insulin treatment of BMECs was capable of reducing VEcadherin phosphorylation at site Y731. Conversely, pPyk2 seemed not to be affected by insulin ( Figure  VIIIA and VIIIB in the onlineonly Data Supplement).
Discussion
This study provides new mechanistic insights into BM endo thelial dysfunction induced by diabetes mellitus. BMECs from T1D mice showed a spectrum of functional alterations, includ ing defects in angiocrine activity, migration, network forma tion, and permeability. Endothelial dysfunction can be traced back to mitochondrial oxidative stress triggered by high levels of glucose and alteration of the RhoA/ROCK/Akt signaling pathway. Moreover, BMEC availability and endothelial barrier dysfunction were confirmed in vivo and corrected by insulin.
RhoA controls several cellular function, including migration, angiogenesis, and apoptosis. [31] [32] [33] In ECs, this Raslike protein is committed to the formation of stress fibers through its effector ROCK. 34 In recent years, RhoA has gained attention in the field of diabetes mellitus, 15, 35, 36 being acknowledged as a primary target for oxidative stress or advanced glycation end products, and as an initiator of a series of transcriptional and posttranscriptional events leading to endothelial dysfunction. 12, 37, 38 Here, we newly demonstrate that diabetes mellitus increases RhoA expression and activity, as well as the mRNA levels of ROCK isoforms in diabetic BMECs. ROCK1 activation is involved in permeability changes under inflammatory conditions, 39 whereas ROCK2 contributes to the increase in adhesion molecules via nuclear factorκB p65. 40 Activation of moesin by ROCKmediated phosphorylation induces rearrangement of the actin cytoskeleton and cell contraction instrumental to endothelial permeability. 41 Importantly, we found that moesin is transcriptionally upregulated and phosphorylated in BMECs of T1D mice, leading to the activation of stress fibers and increased permeability to MNCs and macromolecules. These effects were prevented by the ROS scavenger and ROCK inhibitor, thus delineating a causal association between oxidative stress, RhoA/ROCK activation, stress fiber contraction, and endothelial barrier dysfunction.
Diabetic endotheliopathy is characterized by an alteration in the phosphorylation state and activity of several kinases.
We have previously reported that diabetic BMECs have higher phosphorylation levels of VEcadherin (at tyrosine 731, the βcatenin-binding site) and Pyk2 (at tyrosine 402, which is the autophosphorylation site for Pyk2) compared with con trol BMECs. 2 Here, we newly report that HGinduced oxi dative stress causes phosphorylation of VEcadherin via the redoxsensitive kinases Src and Pyk2, thereby favoring the disassembly of adherens junctions and BMMNC extrava sation. Furthermore, we found that both diabetes mellitus and HG trigger the phosphorylation of apoptosisrelated kinases, such as p38 and cJun Nterminal kinases, in human and murine cells. The redoxsensitive MAPK kinase kinase, MEK1, which in turn activates extracellularsignalregulated kinases 1/2 exerts a modulatory control of angiogenesis. 42 We found that in vitro exposure of hBMECs to HG increases the phosphorylation of MEK1, however, MEK1 levels were simi lar in BMECs from diabetic or nondiabetic mice. Thus, this specific pathway seems to be particularly sensitive to acute increases in glucose levels. We also observed a differential effect of various antioxidants on vascular permeability. The alteration of endothelial barrier function diabetes mellitus is more likely to depend on the formation of peroxynitrite, which is an activator of the RhoA/ROCK pathway, whereas redoxsensitive kinases are triggered by an increase in hydro gen peroxide production.
Another hallmark of BM endotheliopathy consists of Akt inactivation. NAC, RhoA dominant negative transfection, and ROCK inhibitor Y27632 were able to rescue Akt activ ity, suggesting an intertwined relationship between redox dependent activation of RhoA-ROCK and Akt suppression. In fact, either inhibiting ROCK or enhancing Akt activity rescued diabetes mellitus-induced dysfunctions, including migratory and angiogenic defects, and increased permeability. Akt seems to be crucial for BMECs to manifest a migratory phenotype, as Akt inactivation in diabetes mellitus reduces their migratory and networkforming capacity, whereas Akt reactivation rescues both defects. In accordance with this hypothesis, we observed an impairment in eNOS activity. Therefore, the picture that emerges from a joint analysis of molecular and functional readouts is that of a contracted and leaky BM endothelium, incapable of responding to migratory signals as a consequence of dysfunctional Akt. In addition, it has been recently shown that Akt is essential for BMECs to convey selfrenewal and differentiation signals to longterm hematopoietic stem cells through the release of angiocrine factors. 3, 4 We newly report the decreased expression of some Aktdependent factors in diabetic BMECs, that is, the Notch ligands JAGGED1 and JAGGED2 and the angiogenic fac tor fibroblast growth factor 2. Further studies are warranted to investigate whether a depressed angiocrine signaling may contribute to BM stem cell depletion in diabetes mellitus.
The increased production of ROS plays a pivotal role in the pathogenesis of diabetes mellitus and the resulting complica tions. Along with several other tissues (kidney, eye, and nervous system), we have shown that oxidative stress plays a pivotal role in diabetic microangiopathy observed in BM. Thus, our results reinforce the concept that antioxidant administration can be helpful in managing diabetic complications. Indeed, several other investigations have been carried out to evaluate the ability of antioxidants to manage diabetic complications. For instance, NAC, vitamin C, vitamin E, and αlipoic acid showed positive results in reducing diabetic complications. [43] [44] [45] [46] However, these previous clinical trials yielded promising yet inconsistent results because of the lack of data regarding opti mal antioxidant concentration required to manage diabetic complications, with the lowest side effects possible. 47 For this reason, it is important to understand the molecular mechanisms triggered by oxidative stress in different tissues so that a sys temic antioxidant approach can be combined with a more tai lored one; for example, ROCK inhibitors have already given promising results in in vitro study tissues other than BM. 15, 48, 49 In summary, the present study highlights a molecular net work responsible for endothelial barrier dysfunction in BM and identifies candidate mechanistic targets for rectification of the dysfunctional phenotype ( Figure IX in the onlineonly Data Supplement). Importantly, insulin replacement exerts signifi cant protection of BM vasculature. The notion that insulin is a potent inducer of Akt, 50 and an inhibitor of RhoA in vascular cells, 51 confirms the validity of the proposed molecular network.
BMspecific microangiopathy might have relevant clinical consequences. First, microvascular rarefaction endangers BM stem cell viability through reduction of perfusion and suspen sion of paracrine trophic signaling. Second, plasma extravasa tion is particularly harmful for a tissue like the marrow that is contained in nonexpandable bone. Third, barrier dysfunction might impinge on the release of stem cells, as illustrated by experiments showing exaggerated spontaneous transendothe lial migration and reduced directed migration toward chemoat tractants. These considerations call for urgent investigation into the status of BM in patients with complicated diabetes melli tus. Here, we show that hBMECs develop typical molecular and functional alterations when exposed to HG. We have also gathered new evidence that microvascular rarefaction occurs together with hematopoietic tissue remodeling and stem cell depletion in BM of diabetic patients. 52 Hence, preserving the fitness of BM microvasculature represents a novel therapeutic target in the management of patients with diabetes mellitus.
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